Skip to Primary Navigation

FTC finalizes order for Ascension to divest surgery centers in $3.9bn deal

A photo of a woman in a hospital bed wearing a hospital gown and hair net and a man with his hands on her leg looking up at a clinician.
Photo: Brooks Kraft LLC/Sygma via Getty Images

The consent order mandates divestitures across five metro areas after regulators concluded the acquisition would reduce competition for key outpatient surgical services.

A consent order requiring Ascension Health Alliance to divest seven AmSurg ambulatory surgery centers as a condition of its proposed $3.9 billion acquisition of AmSurg LLC has been finalized by the Federal Trade Commission (FTC).

In June settlement documents, the FTC said the divestitures are necessary to preserve competition for

Six

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience